Repositioning salicylanilide anthelmintic drugs to treat adenovirus infections

The repositioning of drugs already approved by regulatory agencies for other indications is an emerging alternative for the development of new antimicrobial therapies. The repositioning process involves lower risks and costs than the de novo development of novel antimicrobial drugs. Currently, infec...

Descripción completa

Detalles Bibliográficos
Autores principales: Marrugal-Lorenzo, José A., Serna-Gallego, Ana, Berastegui-Cabrera, Judith, Pachón, Jerónimo, Sánchez-Céspedes, Javier
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6327057/
https://www.ncbi.nlm.nih.gov/pubmed/30626902
http://dx.doi.org/10.1038/s41598-018-37290-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6327057/
https://www.ncbi.nlm.nih.gov/pubmed/30626902
http://dx.doi.org/10.1038/s41598-018-37290-3

Ejemplares similares